<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-timolol.xml</id>
  <title>Recalls Watch: Timolol</title>
  <link rel="self" href="https://recalls.watch/feed/substance-timolol.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-08-05T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99481/</id>
    <title>MICRO LABS USA INC: Dorzolamide HCl and Timolol Maleate Ophthalmic Solution</title>
    <link href="https://recalls.watch/recall/fda/99481/"/>
    <updated>2026-08-05T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98536/</id>
    <title>Apotex Corp.: Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*</title>
    <link href="https://recalls.watch/recall/fda/98536/"/>
    <updated>2026-03-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97561/</id>
    <title>Apotex Corp.: Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97561/"/>
    <updated>2025-10-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97219/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution USP</title>
    <link href="https://recalls.watch/recall/fda/97219/"/>
    <updated>2025-08-06T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: spike of the cap becomes lodged in the nozzle of the product bottle.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96954/</id>
    <title>Apotex Corp.: Ketorolac Tromethamine Ophthalmic Solution and 2 more</title>
    <link href="https://recalls.watch/recall/fda/96954/"/>
    <updated>2025-07-02T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96740/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution USP</title>
    <link href="https://recalls.watch/recall/fda/96740/"/>
    <updated>2025-05-14T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96196/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution USP</title>
    <link href="https://recalls.watch/recall/fda/96196/"/>
    <updated>2025-02-12T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95921/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution USP</title>
    <link href="https://recalls.watch/recall/fda/95921/"/>
    <updated>2024-12-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95648/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution USP</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95648"/>
    <updated>2024-11-13T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/95140/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution USP</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=95140"/>
    <updated>2024-08-28T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: patients are unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94990/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution USP</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94990"/>
    <updated>2024-08-21T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective container; yellow colored spike from cap lodged in the nozzle</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94466/</id>
    <title>FDC Limited: Timolol Maleate Ophthalmic Solution</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94466"/>
    <updated>2024-05-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94146/</id>
    <title>Thea Pharma, Inc.: Betimol</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94146"/>
    <updated>2024-03-20T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/91788/</id>
    <title>Akorn, Inc.: Atropine Sulfate Ophthalmic Solution and 85 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=91788"/>
    <updated>2023-06-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations: Firm went out of business and could no longer continue stability studies.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/90948/</id>
    <title>Akorn, Inc.: AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic Ointment USP and 26 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=90948"/>
    <updated>2023-01-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations:</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/90720/</id>
    <title>Akorn, Inc: Timolol Maleate Ophthalmic Solution</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=90720"/>
    <updated>2022-09-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications: Identification of an unknown impurity at the 12-month stability point.</summary>
  </entry>
</feed>
